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Abstract 
 
Background: Lymphedema treatment is difficult and there is no consensus on the best treatment. This study 
evaluated the effect of combined decongestive therapy (CDT) and pneumatic compression pump on lymphede-
ma indicators in patients with breast cancer related lymphedema (BCRL). 
 
Methods: Twenty one women with BCRL were enrolled. The volume difference of upper limbs, the circumfer-
ence at 9 areas and shoulder joint range of motion were measured in all patients. CDT was done by an educated 
nurse in two phases. In first phase, CDT was accompanied by use of a compression pump for 4 weeks, 3 days 
per week. In second phase, CDT was performed daily without compression pump for 4 weeks by patients at 
home. At the end of each phase, the same primary measurements were done for patients.  
 
Results: The mean volume difference of the upper limbs and mean difference in circumference in all areas at 
different phases decreased significantly. Mean flexion, extension, abduction and external rotation (in degrees) at 
different phases increased significantly.  
 
Conclusion: CDT significantly reduced mean volume and mean circumference of the affected limb, and signifi-
cantly increased shoulder joint range of motion. The findings support the optimal effects of CDT in the treatment 
of secondary lymphedema of upper extremity. 
Clinical trial registration number: 138902212621N8 
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Introduction 
 
Patients with breast cancer undergo surgical treatment 
(mastectomy) accompanied by axillary node dissec-
tion and radiotherapy. These treatments impair lym-
phatic drainage of the affected upper limb, and place 
patients at risk for secondary lymphedema, which has 
been reported at rates ranging from 10.0% to 49.0%. 
Breast cancer-related lymphedema (BCRL) is defined 
as edema in the upper extremity, due to the insuffi-
cient drainage of lymph -a serious and disabling 
complication of breast cancer treatment. This disor-
der, which often appears 18-24 months after breast 
cancer treatment is gradual, chronic and progressive 
and also resistant to treatment.
1   The incidence of 
lymphedema after breast cancer treatment, is variable 
and has been reported between 0.2% and 65.0%.
2-4  
Also Different diagnostic criteria for lymphedema 
resulted in different reported prevalence in different 
studies. On average, of each 4-6 women who undergo 
breast cancer treatment, one suffers from lymphede-
ma.
1 The US National Cancer Association has esti-
mated the prevalence of lymphedema following met-
astatic breast cancer to be 9.6 million persons, of 
which 61.0% (5.86 million) aged over 65 years old.
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Despite current models for the treatment of breast 
cancer, lymphedema has remained a major health 
problem for these patients.
6 Lymphedema treatment is 
difficult and requires long-term or lifelong physical 
therapy.
7 For many years, the treatment of this disor-
der has been controversial,
8  and the literature con-
tains no evidence to suggest the most effective treat-
ment for secondary lymphedema.
9 Many specialists 
believe that treatment of most types of lymphedema 
should be primarily conservative.
10 Keeping the upper 
limb elevated, exercise, compression sleeve, massage 
therapy, combined decongestive therapy (CDT), 
pneumatic compression pump, surgery, laser therapy, 
and drug therapy are among the methods used to treat 
lymphedema.
1 But so far, surgery and drug therapies 
have not been successful.
11,12  The CDT method was 
developed initially in the late 1800s by Winiwarter 
and then modified by the Vodders in the 1930s.
13  In 
this method, compression bandaging, manual lym-
phatic drainage (MLD), exercises to increase lymph 
circulation and skin care are used.
1,12  Use of a com-
pression pump is not a common part of CDT, but 
could be used as a complementary treatment.
6  
Several case series have indicated the efficiency of 
CDT in reducing lymphedema and the circumference of 
the affected limb; however, sufficient evidence to sup-
port this therapeutic method is so far unavailable.
14  
Nurses, as important members of the rehabilitation 
team, play an important role in the prevention, educa-
tion and treatment of patients who survive breast can-
cer, and can also play an active role in the education, 
diagnosis and prevention of complications. Thanks to 
their knowledge of lymphedema, nurses can provide 
rapid and timely interventions to reduce the severity 
of lymphedema in these patients.
15,16 The increasing 
rates of diagnosis and treatment of breast cancer are 
resulting in an increase in the incidence of 
lymphedema in these patients. Accordingly, rehabili-
tation services provided at lymphedema clinics and 
research regarding treatment for this complication is 
needed. Previously, patients with lymphedema in our 
setting had little access to centers in Tehran for treat-
ment. The personal expense and psychological pres-
sure involved in obtaining information and receiving 
treatment, remain considerable. Moreover, therapeu-
tic specialists lacked the necessary technical and prac-
tical expertise to manage lymphedema. Only one 
study related to treatment of lymphedema has ap-
peared in Iran.
17  Therefore, the aim of this follow up 
study was to investigate the effect of CDT in combi-
nation with compression pump therapy on 
lymphedema indicators including  circumference, vol-
ume and range of shoulder joint motions in the upper 
limb affected by BCRL. 
 
 
Materials and Methods 
 
This follow up study involved women referred to the 
Shahid Mottahari Therapeutic Center in Shiraz be-
tween October 2009 and December 2009 (southwest-
ern Iran). Initially 21 patients who met the inclusion 
criteria agreed to participate and provided their in-
formed consent in writing. The inclusion criteria were 
a diagnosis of unilateral breast cancer, history of sur-
gery, chemotherapy and (if required) hormone re-
placement-therapy and radiotherapy, a diagnosis of 
lymphedema based on assessment by a specialist, 
mild to severe degree of lymphedema at least 1 year 
elapsed since axillary node dissection, no being ex-
posed or received CDT, telephone access and age be-
tween 35 and 70 years. Before the intervention, we 
measured the circumference and volume of both up-
per limbs and joint range of motion in the affected 
shoulder in all patients. All measurements were done 
between 8.00 and 14.00 hours.  
Upper limb edema was investigated by measuring 
the circumference of both upper limbs at 9 areas (as  
previously done by study 10)  with a retractable, fi-
berglass, 150-cm measuring tape and calculating the 
difference. Measurements were made at the olecra-
non, 10, 15 and 20 cm above and below the olecra-
non, at the wrist and at the metacarpophalengeal joint. 
All measurements were made by the same investiga-
tor (a nurse) who used the same procedure at all 
times. Measurements were recorded as the baseline 
data, 4 and 8 weeks after treatment. 
Upper limb volume was measured by water vol-
ume displacement. This method is as the "gold stand-
ard" for volumetric measurements and determining 
volume reduction in patients with lymphedema.
16 
Volumes were measured in a pair of specially-
constructed cylindrical plexi-glass tanks, each with 
two drainage taps. The main (internal) tank measured 
70.0 cm in height by 21.0 cm in diameter. The exter-
nal tank measured 60 cm in height and 31.0 cm in 
diameter. The section area of the internal tank was 
330.0 cm². The internal tank was filled with water to 
a height of 70.0 centimeters. The outer wall of the 
external tank was marked in centimeters and millime-
ters to measure the height of the water that over-
flowed from the inner tank. The patient stood next to Moattari et al. 
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the device and immersed her straightened healthy 
hand and arm into the inner tank up to a point 15.0 
centimeters above the olecranon. The height of the 
displaced water and that spilled into the outer tank 
was recorded in centimeters. The patient then re-
moved her healthy upper limb and immerses her af-
fected hand and arm into the internal tank, and the 
height of the displaced water was again recorded. The 
difference between the two measurements was multi-
plied by the section area of the inner tank (330.0 cm) 
to calculate the volume of water in milliliters dis-
placed by the arm with lymphedema compared to the 
unaffected limb.  
The range of flexion, extension, abduction, adduc-
tion and external rotation in the affected shoulder joint 
was measured with a standard goniometer (based on 
degree) by the same researcher in all women before 
CDT therapy and 4 and 8 weeks after. To ensure accu-
racy flexion, extension, abduction and adduction were 
measured with the patient in standing position and ex-
ternal rotation of the shoulder joint was measured with 
the patient in prone position. Patients received treat-
ment with CDT and compression pumping. The ac-
complishment of the combined decongestive therapy 
techniques was conducted by one of the researchers 
and concerning the conduction of these techniques, no 
expenses was taken from the patients. 
The first phase (therapeutic phase) of CDT was 
done at the clinic where compression pumping was 
also used to reduce upper limb volume. Each patient 
received 3 weekly sessions during 4 weeks and each 
session lasted 60-90 min. In each session, one of the 
researchers first performed MLD for 30-40 min and 
then affected upper limb was placed in the compres-
sion pump for 15 min. Then the affected limb was 
bandaged with multilayer compression bandages and 
remedial exercises were done to increase the lymph 
circulation. During these sessions, written and verbal 
information were provided regarding  skin and nail 
care, care of the bandaging and practical training in 
MLD, how to bandage the upper limb and remedial 
exercises, and they were prepared for the second 
phase (maintenance phase), which consisted of long-
term self-care to maintain the limb size. To ensure 
compliance with the instructions and advice regarding 
self-care, the patients were asked to perform these 
techniques by themselves during sessions in the se-
cond half of the first phase of intervention (third to 
fourth weeks). During the second treatment phase, 
patients performed CDT daily at home for a period of 
4 weeks. They were given a telephone number to con-
tact for help at any time, and during the second phase, 
each patient was contacted weekly by telephone by 
the second author to ask whether she needed any help 
with her self-care. Each patient completed a daily 
checklist on self-care, and use of the checklist was 
verified during the weekly telephone contact. 
At the end of each phase (4 and 8 weeks after 
starting therapy), displaced water volume, limb cir-
cumference and shoulder joint range of motion in the 
affected upper limb were measured again. The data 
were analyzed with analytical and descriptive statis-
tics in SPSS software (version 17.0, Chicago, IL, 
USA). Correlation coefficient between the two meth-
ods of volume and circumferential measurements of 
the upper limbs were examined by Pearson correla-
tion test. Descriptive statistics included absolute and 
percentage frequencies, means and standard devia-
tions. Mean values of data (displaced water volume, 
limb circumferences in 9 areas of the affected limb 
minus the same measures in unaffected limb and the 
degree of shoulder joint range of motion in the affect-
ed upper limb) at different phases of study were com-
pared with a repeated measurement design.  
 
 
Results 
 
Findings of the study were presented in four tables. 
Demographic data of the patients were presented in 
Table 1. Results of correlations between two methods 
of measurement were shown in Table 2. Upper limb 
circumference and limb volume were shown in Table 
3. Range of shoulder joint motions was presented in 
Table 4.  
Before intervention, the correlation coefficient be-
tween two methods of volume and circumferential 
measurements of the upper limbs were examined, and 
it was found that correlation coefficient between two 
methods of measuring was more than 0.8 in all areas 
except for  20 cm above the olecranon, wrist and met-
acarp which  was 0.77,0.6 and 0.53 respectively. 
The mean difference in circumference between the 
two upper limbs at different phases of study de-
creased significantly at all levels including metacar-
pophalengeal, wrist, 10 cm below olecranon, 15 cm 
below olecranon, 20 cm below olecranon, olecranon,  
10 cm above olecranon, 15 cm above olecranon and 
20 cm above olecranon (p<0.05) (Table 3). 
  The differences in mean volume between the 
two upper limbs 4 and 8 weeks after the interven-Decongestive therapy in lymphedema 
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tion were smaller than before treatment (p<0.001) 
(Table 3).  
Mean range of flexion (p<0.001), extension 
(p<0.004), abduction (p<0.001) and external rotation 
(p<0.001) increased 4 and 8 weeks after treatment 
(Table 4).  
Due to the fact that, at 4 and 8 weeks after starting 
intervention, all amounts related to adduction motion 
of shoulder joint have become zero therefore, test was 
not carried out (of course, the normal amount of ad-
duction of shoulder joint is zero degree and could be 
stated that, the mean of adduction motion of shoulder 
Table 1: Characteristics of the patients.
n=21 
Age (years) 
Mean±SD 
Range  
 
50.38±9.92 
35-70 
Educational level 
Illiterate 
Late primary education (from 12 to 14 years) 
Secondary education 
University education 
 
4.8% 
14.3% 
47.6% 
33.3% 
Marietal status 
Single 
Married 
 
4.8% 
95.2% 
Type of operation (%) 
Breast-preserving procedures 
Modified radical mastectomy 
Radical mastectomy 
 
42.9 
38.1 
19 
Lymph node removed (number) mean±SD  3.28±3.60 
Degree of lymphedema 
Degree 1 
Degree 2 
Degree3 
 
0 
47.6 
52.4 
Affected arm (%) 
Dominant  
Non-dominant 
 
52.4 
47.6 
Non-Surgical Treatments (%) 
HRT
a 
RT
b 
CT
c 
 
81 
95.2 
100 
aHRT=Hormone-replacement therapy, 
bRT=Radiotherapy, 
cCT=Chemotherapy. 
 
 
Table 2: Correlations between the mean difference in circumferences and mean volume dis-
placement of both upper limbs before the intervention. 
Mean volume difference of both upper limbs be-
fore the intervention based on mL (n=21) 
Mean difference in circumferences of 
both upper limbs before the interven-
tion (based on cm)  P value  Pearson correlation
0.004  0.597  Wrist 
0.014  0.528  Metacarp 
0.001  0.870  Below 20 
0.001  0.852  Below 15 
0.001  0.800  Below 10 
0.001  0.920  Olecranon 
0.001  0.808  Above 10 
0.001  0.900  Above 15 
0.001  0.777  Above 20 
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joint in patients participated in this research before 
beginning of intervention also has been near to nor-
mal range and shoulder joint adduction motion in   
patients with breast cancer related lymphedema as   
compare with other shoulder motions suffer lesser 
from this disorder).  
 
 
Discussion 
 
Upper limb lymphedema is a common complication 
of breast cancer treatments.
18 At present, CDT is a 
popular, conservative treatment for lymphedema; 
however, the relative efficacy of its different compo-
nents has not been investigated.
12 In the present study, 
the circumference measurements of both upper limbs 
were carried out at 9 areas, however in one study, it 
was emphasized that these measurements should be 
performed at least at 4 areas including metacarpal 
joints, wrists, 10 cm below olecranon and 15 cm 
above olecranon, existence of more than 2 cm differ-
ence in each of these 4 areas between two upper limbs 
considered as lymphedema diagnosis.
6  
Furthermore, using water volume displacement is 
propounded as a golden standard to evaluate 
lymphedema,
16  but applying this method along with 
measuring limb circumference has been emphasized in 
other studies.
19 Therefore, in present study, both meth-
ods were used to evaluate lymphedema. However we 
found that the correlation coefficient between two 
methods of volume  and circumferential measurements 
in all 9 areas was significant, ranging from 0.528 to 
0.92. It is noteworthy to mention that circumferential 
measures of limbs usually performed at bony land-
marks. In one study,
20 this measurement method was 
done at wrist, metacarp, 10 cm below and 15 cm above 
the olecranon. Correlations we found between two 
methods of measurement was relatively strong in just 
three of this four areas, and relatively weak in the meta-
carpal area.  Therefore, we suggest further studies for 
determining the best areas of upper limbs for measure-
ment of lymphedema if volumetric measurement is not 
practical. 
Table 3: The comparison of the affected arm edema at different phases of study
Affected arm edema  Before treatment 
mean±SD 
4 Weeks
mean±SD 
8 Weeks
mean±SD 
P value 
Circumferential 
measurement (cm): 
      
MCP
a 1.63±1.56  0.87±1.29  0.72±0.80  0.001 
Wrist 2.01±1.69  1.28±1.03  1.25±1.12  0.014 
Olecranon 4.56±2.35  3.21±1.81  2.50±1.73  0.001 
10↓ 5.21±3.06  3.63±2.08  3.45±1.96  0.001 
15↓ 5.93±3.34  3.95±2.24  3.92±2.44  0.001 
20↓ 5.24±3.13  3.57±2.21  3.32±2.23  0.001 
10↑ 4.40±2.90  3.32±2.31  3.29±1.97  0.022 
15↑ 3.74±2.91  2.69±2.04  2.62±1.72  0.006 
20↑ 2.83±2.23  1.96±1.60  1.66±1.54  0.001 
Volumetric  
measurement (mlt) 
802.23±479.68 561.00±303.48  590.85±362.38  0.001 
aMCP: Metacarpophalengeal, statistically significant p< 0.05. 
 
 
Table 4: The comparison of the mean of shoulder joint motions at different phases of study. 
Range of motion (°)  Before treatment 
mean±SD 
4 Weeks
mean±SD 
8 Weeks
mean±SD 
P value
a
Flexion 
Extention 
Abduction 
Adduction 
External rotation 
144.76±11.33 
46.04±7.74 
153.23±11.25 
0.47±2.18 
67.71±14.00 
153.38±10.55 
51.57±5.37 
161.52±9.76 
0.00±0.00 
78.33±10.87
151.28±11.53 
51.19±5.45 
158.71±8.70 
0.00±0.00 
83.76±8.61
0.001 
0.004 
0.001 
Not done 
0.001 
aStatistically significant p<0.05. Decongestive therapy in lymphedema 
 
WWW.ircmj.com Vol 14 April 2012  215
Significant decrease in the mean difference in cir-
cumference of both upper limbs (at 9 areas), 4 weeks 
after treatment and the permanency of this reduction 8 
weeks after study at 8 areas indicates the positive ef-
fects of maintenance phase as well as therapeutic 
phase of CDT along with compression pumping and 
effective education of CDT techniques in the form of 
a self management program to the patients. 
Performed interventions to reduce lymphedema 
have been various. In most of studies, the object has 
been the comparison of the effect of various parts of 
CDT with each other. For example, in a study, the 
effect of two methods of MLD along with compres-
sion bandaging and compression bandaging alone 
were evaluated. Results indicated that both methods 
were effective in lymphedema volume reduction.
16 In 
another study, also the effect of compression bandag-
ing with low elasticity alone and compression band-
aging in combination with MLD were compared and 
results indicated that compression bandaging with 
low elasticity was an effective treatment to reduce 
mild and moderate lymphedema volume but, adding 
MLD to the compression bandage was more effec-
tive.
21 In another study, remedial exercise along with 
compression garments were used.
20 At the end of first 
month, there was significant decrease in circumfer-
ence in two areas (wrist and 15 cm above olecranon). 
But, in the present study, in which CDT along with 
compression pumping were used, 4 weeks after 
treatment comparing prior to that, the mean difference 
in circumference of both upper limbs at all measuring 
areas decreased significantly. Therefore, considering 
the similarity of demographic characteristics of under 
studied groups in these two studies, we may say that, 
performing CDT accompanied by use of compression 
pumping exhibited more desirable results comparing 
with remedial exercise along with compression gar-
ments. In the second phase of a study, also the effect 
of MLD was compared with the effect of compres-
sion pumping. The results showed that MLD and 
compression pumping effectively reduced 
lymphedema volume and no any statistical signifi-
cant difference was existed between the obtained 
results of these two treatment methods.
22 In other 
studies, the effect of CDT was compared with the 
effect of CDT along with compression pump-
ing.
17,18,23 In spite of the fact that, these intervention 
were similar but, obtained contradictory results in 
such a way that, Szuba et al. (2002) and Szolonky et 
al. (2002) concluded that, CDT along with compres-
sion pumping reduced the limb volume more effec-
tively but, Haghighat et al. (2010) concluded that, 
CDT alone or in combination with compression 
pumping reduced the limb volume significantly but, 
CDT alone exhibited better results. 
In other studies, the effect of simple lymphatic 
drainage (which is performed by patients) was com-
pared with MLD (which is performed by expert ther-
apist). The results of these studies showed that MLD 
reduced the lymphedema volume more significantly 
than the simple lymphatic drainage.
24,25 In our study, at 
the time of 8 weeks after treatment, there was no signifi-
cant difference in the mean difference in circumference 
of both upper limbs at all measuring areas comparing 
with 4 weeks after that. This result represents the con-
tinuance of obtained results from therapeutic phase 
throughout maintenance phase. It should be considered 
that, as a fact, the most edema reduction rate occurred 
during the first week of CDT performance and at the 
end of forth week of therapeutic phase, edema volume 
reduced less and slower.
26 At the second phase of CDT, 
if no increase occurs in the reduced size of the limb, 
patients obtained the desirable and considered results.
27 
In a study, the therapeutic phase of CDT was performed 
5 days per week for a period of 4 weeks and thereafter, 
patients were undergone maintenance therapy for a pe-
riod of one year. The difference in circumference of 
both upper limbs as well as volume difference of both 
upper limbs was measured at the end of therapeutic 
phase, 3 months, 6 months and one year after beginning 
of intervention. Results indicated that, 3 months after 
starting intervention (beginning of maintenance phase), 
difference in circumference of both upper limbs had 
reduced on an average by 1.5 centimeters at the end of 
therapeutic phase. Thereafter, slightly increased and till 
one year after starting intervention remained constant 
about 1 cm lower than the size of the study beginning. 
Also, volume difference of both upper limbs, reduced 
by 138 ml at the end of therapeutic phase and thereaf-
ter, slightly increased 3 months after study beginning 
and till 1 year after starting intervention remained con-
stant about 100 ml lower than the amount of starting 
intervention.
28  
In our study, the mean difference in circumference 
of both upper limbs, 8 weeks comparing with 4 weeks 
after treatment, not only has not been increased but, 
has been reduced insignificantly. This indicates that, 
by performing self management program at second 
phase of treatment, patients could maintain their limb 
volume reduction. The results of the present study 
indicated that, the mean volume difference of the up-
per limbs and mean difference in circumference in all Moattari et al. 
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areas measured at different phases decreased signifi-
cantly. The changes of these two variables are indi-
cating the optimal effects of CDT along with com-
pression pumping in lymphedema treatment. 
  The results related to the mean difference in vol-
ume of both upper limbs, 8 weeks comparing with 4 
weeks after starting intervention is similar to the ob-
tained results from circumference measurement of 
both upper limbs. In a study, it was shown that a sig-
nificant volume decrease which was obtained at the 
end of first phase, prolonged 9 months after starting 
treatment and it was specified that, in patients adapted 
with treatment (86.0% of patients), 90.0% of volume 
primary reduction in upper and lower limbs has been 
preserved and patients not adapted to treatment, lost 
33.0% of volume reduction of their limbs.
29  
The obtained results from the measuring of shoul-
der joint range of motion is indicating that, perform-
ing CDT along with  compression pumping, im-
proved the range of motions of flexion, extension, 
abduction and external rotation of shoulder joint in 
these patients. In our study, the most recovery has 
been exhibited in external rotation of shoulder joint 
and it could be concluded that, CDT along with com-
pression pumping was so effective in the improve-
ment of external rotation of shoulder joint that affect-
ed with lymphedema. In this regard, it should be tak-
en into consideration that the created limitation in the 
range of external rotation of shoulder joint comparing 
with its other motions would be relieved immediately 
following by CDT.
30 In a study, the effects of CDT 
and standard physiotherapy in the treatment of 
lymphedema secondary to breast cancer were com-
pared. After treatment, the range of shoulder flexion 
and abduction increased significantly in both groups 
(p<0.05). Results indicated that, although patients of 
both groups experienced the range of motion incre-
ment and lymphedema decrement but, total recovery 
in the CDT group was more than that of standard 
physiotherapy group.
12 Although the duration of CDT 
in their study was similar to our study but, performing 
CDT in their study resulted in improvement in the 
shoulder flexion and abduction only. But, the results 
of present study are indicating to a significant in-
crease in the range of shoulder flexion, extension, 
abduction and external rotation in such a way that, the 
range of these motions has reached to the normal 
amount. Of course, it is suggested to consider the 
evaluation of shoulder joint range of motion on the 
basis of comparing the range of motions of joints from 
both upper limbs with each other in other studies. 
CDT along with compression pumping reduced the 
difference in upper limbs circumference and the differ-
ence in volume between the affected and unaffected 
limb. Patient education in CDT skills can enable them 
to maintain the reductions in limb measurements 
achieved by ambulatory treatment. The use of com-
pression pumping together with CDT was effective in 
increasing the range of shoulder joint motions. Nurses 
can play a potentially important role in providing 
lymphedema therapy and patient education and support 
which can increase the effectiveness of treatment. 
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